Tilray Brands, INC

Tilray Brands announced record fiscal year 2026 revenue of $915 million and record Adjusted EBITDA, driven by strong performance in its cannabis, beverage, and distribution segments, with a positive outlook for fiscal year 2027.

Tilray Brands issued over 2.6 million shares of common stock to settle $12 million in convertible notes.

Tilray Brands announced a debt-for-equity exchange, issuing 1,214,186 shares of common stock for $6 million in convertible notes.

Tilray Brands, Inc. has filed a prospectus supplement for the resale of 398,666 shares of its common stock.

Tilray Brands announced an at-the-market equity program of up to $180 million to fund global beverage expansion and strategic initiatives, including the acquisition of UK-based Lyphe Group.

Tilray Brands reported record third-quarter fiscal 2026 net revenue of $206.7 million and gross profit of $55.0 million, driven by strong international cannabis growth and strategic beverage acquisitions.

Tilray Brands reported a significantly reduced net loss in its third fiscal quarter, driven by non-recurring prior-year impairments and strategic acquisitions, while expanding its global beverage alcohol business with the acquisition of BrewDog assets.

Tilray Brands reported a significant reduction in net loss for the quarter ended November 30, 2025, driven by growth in its cannabis and distribution segments, despite declines in its beverage business.

Tilray Brands, Inc. reported a significant swing to net income and improved cash flow from operations and investing activities for the quarter ended August 31, 2025, despite slight revenue growth and declining gross margins in key segments.

Tilray Brands reports its Q3 2025 financial results, highlighting a net loss driven by substantial non-cash impairment charges and strategic business realignments.

Tilray Brands reports increased revenue but continues to experience net losses in Q2 2025 as it navigates strategic acquisitions and market challenges.

Tilray Brands' latest quarterly report reveals a complex financial landscape marked by strategic acquisitions, fluctuating market conditions, and ongoing cost optimization efforts.

Tilray Brands, Inc. has filed its Annual Report on Form 10-K for the fiscal year ended May 31, 2026, detailing its financial performance, strategic initiatives, and risk factors across its cannabis, beverage, distribution, and wellness segments.

Tilray Brands, Inc. reported a substantial net loss of $2.18 billion for fiscal year 2025, primarily driven by non-cash impairment charges totaling over $2 billion on intangible assets and goodwill, despite revenue growth in its beverage, distribution, and wellness segments.

Tilray Brands Inc. releases its annual 10-K filing, detailing its financial results, strategic initiatives, and future outlook across its cannabis, beverage, wellness, and distribution segments.

Carl A Merton, Chief Financial Officer of Tilray Brands, Inc., purchased 10,000 shares of common stock on August 4, 2026 for $4.62 per share.

Denise M Faltischek, Chief Strategy Officer of Tilray Brands, Inc., purchased 2,500 shares of common stock on August 3, 2026 for $4.78 per share.

Irwin D Simon, President and CEO and a Director of Tilray Brands, Inc., reported multiple transactions in common stock on July 29, 2026.

Carl A Merton, Chief Financial Officer of Tilray Brands, Inc., reported multiple transactions in common stock on July 29, 2026.

Mitchell Gendel, Global General Counsel of Tilray Brands, Inc., reported multiple transactions in common stock on July 29, 2026.

Denise M Faltischek, Chief Strategy Officer of Tilray Brands, Inc., reported multiple transactions in common stock on July 29, 2026.

Tilray Brands, Inc. has filed definitive additional proxy soliciting materials with the SEC.

Tilray Brands, Inc. announces its 2025 Annual Meeting of Stockholders to vote on director election, auditor ratification, executive compensation, and a significant governance proposal to declassify its Board.

Tilray Brands, Inc. has filed a definitive proxy statement with the Securities and Exchange Commission.

Tilray Brands is asking stockholders to approve a reverse stock split to maintain its Nasdaq listing and potentially attract institutional investors.

Tilray Brands has won a court case regarding the voting standard for share authorization and has rescheduled the adjourned portion of its annual meeting to December 19, 2024.

Tilray Brands is being sued by a stockholder who alleges the company made misleading statements in proxy materials regarding voting standards for increasing authorized shares.